Verici DX (VRCI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 8.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 17.50
  • 52 Week Low: 5.75
  • Currency: UK Pounds
  • Shares Issued: 242.54m
  • Volume: 85,868
  • Market Cap: £19.40m
  • RiskGrade: 429

Latest ShareCast News

Verici Dx completes analytical validation on two assays

By Josh White

Date: Tuesday 15 Feb 2022

(Sharecast News) - Clinical diagnostics developer Verici Dx announced on Tuesday that its two lead in-vitro diagnostic assays, 'Clarava' and 'Tuteva', had completed analytical validation under the CLIA requirements, meeting criteria for robust assay performance.

Verici Dx enters collaboration with Nasdaq-listed Illumina

By Josh White

Date: Wednesday 05 Jan 2022

(Sharecast News) - Organ transplant clinical diagnosis developer Verici Dx announced a collaboration with Nasdaq-listed Illumina on Wednesday, to expedite the operational launch of data analysis processing and the predictive artificial intelligence component of its products using early access to Illumina's new software platform ICA.

Verici granted 'fundamental' codes for tests in US market

By Josh White

Date: Tuesday 04 Jan 2022

(Sharecast News) - Organ transplant diagnostics company Verici Dx has been granted 'CPT' proprietary laboratory analyses (PLA) codes for both its 'Clarava' and 'Tuteva' tests by the American Medical Association (AMA), it announced on Tuesday.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Verici DX Market Data

Currency UK Pounds
Share Price 8.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 17.50
52 Week Low 5.75
Volume 85,868
Shares Issued 242.54m
Market Cap £19.40m
RiskGrade 429

Verici DX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.85% below the market average35.85% below the market average35.85% below the market average35.85% below the market average35.85% below the market average
24.53% below the sector average24.53% below the sector average24.53% below the sector average24.53% below the sector average24.53% below the sector average
Price Trend
51.17% below the market average51.17% below the market average51.17% below the market average51.17% below the market average51.17% below the market average
19.30% above the sector average19.30% above the sector average19.30% above the sector average19.30% above the sector average19.30% above the sector average
Income Not Available
Growth Not Available

Verici DX Dividends

No dividends found

Trades for 16-Apr-2024

Time Volume / Share Price
10:00 35,868 @ 8.35p
08:10 50,000 @ 7.75p

Verici DX Key Personnel

CEO Sara Barrington

Top of Page